```html

Quinolone‑Associated Tendon Rupture

Overview

Quinolone‑associated tendon rupture (QATR) is a rare but serious adverse effect of systemic fluoroquinolone antibiotics such as ciprofloxacin, levofloxacin, and moxifloxacin. These broad‑spectrum agents are prescribed for respiratory, urinary‑tract, and gastrointestinal infections, yet they can weaken tendons—most often the Achilles tendon—leading to partial or complete tears.

Who it affects: The condition can occur in any age group, but epidemiologic data show a higher incidence in adults over 60 years, in individuals taking corticosteroids, and in patients with pre‑existing tendon disease.

Prevalence: Large‑scale pharmaco‑epidemiologic studies estimate an incidence of 0.1–0.4 % per fluoroquinolone course, translating to roughly 1–4 cases per 1,000 treated patients (FDA, 2022; FDA Safety Communication, 2016). The Achilles tendon accounts for about 70 % of reported ruptures, followed by the rotator cuff and biceps tendon.<sup>[1][2]</sup>

Symptoms

Symptoms may appear suddenly or develop over days to weeks after starting a fluoroquinolone. Key findings include:

• Pain – Sharp or aching pain localized to the affected tendon, often worsening with weight‑bearing or movement.
• Swelling – Visible puffiness or a feeling of fullness around the tendon.
• Warmth & redness – The area may feel warm to the touch, indicating inflammation.
• Decreased strength – Difficulty pushing off the ground (Achilles) or lifting objects (biceps).
• “Pop” sensation – Some patients describe hearing or feeling a sudden “pop” at the moment of rupture.
• Visible gap – In complete ruptures, a palpable gap may be felt in the tendon.
• Functional limitation – Inability to walk on tip‑toes, climb stairs, or raise the arm above shoulder level.
• Night pain – Discomfort that disrupts sleep.

Symptoms can be subtle in the early phase, mimicking tendonitis. Prompt recognition is essential to prevent full‑thickness rupture.

Causes and Risk Factors

Mechanism of injury

Fluoroquinolones interfere with collagen synthesis by chelating magnesium ions and generating oxidative stress within fibroblasts, resulting in tendon matrix weakening. Animal studies have demonstrated dose‑dependent degeneration of collagen fibers and reduced tensile strength of tendons after fluoroquinolone exposure.<sup>[3]</sup>

Major risk factors

• Age ≥ 60 years – Tendons naturally lose elasticity with aging.
• Concurrent corticosteroid therapy – Steroids synergistically impair collagen production.
• Recent or chronic tendon pathology – Prior tendinitis, tendinosis, or previous surgery.
• Renal impairment – Reduced drug clearance increases tissue exposure.
• High‑intensity physical activity – Athletes, walkers, or laborers who stress the Achilles.
• Obesity – Greater mechanical load on weight‑bearing tendons.
• Genetic predisposition – Polymorphisms in collagen‑related genes have been implicated (preliminary data).

If any of these factors are present, clinicians often choose alternative antibiotics (e.g., trimethoprim‑sulfamethoxazole, doxycycline) when appropriate.

Diagnosis

Diagnosis is primarily clinical, supported by imaging when needed.

History and physical exam

• Document recent fluoroquinolone use (drug, dose, duration).
• Assess onset, location, and nature of pain.
• Perform specific maneuvers: Thompson test for Achilles rupture, squeeze test for biceps, and shoulder abduction for rotator‑cuff involvement.

Imaging studies

• Ultrasound – Real‑time assessment of tendon continuity; useful in office settings.
• MRI – Gold standard for detecting partial tears, tendon retraction, and associated edema.
• Plain radiographs – Typically normal but can rule out associated fractures.

Laboratory tests

Routine labs are not diagnostic but may help rule out infection or systemic disease:

• Complete blood count (CBC) – rule out leukocytosis.
• Erythrocyte sedimentation rate (ESR) / C‑reactive protein (CRP) – may be mildly elevated with inflammation.
• Serum creatinine – important for dosing considerations in renal impairment.

Treatment Options

Management is tiered from conservative measures to surgical repair, guided by the severity of the rupture and patient factors.

Immediate actions

1. Discontinue the fluoroquinolone immediately. Switch to an appropriate alternative based on infection type and susceptibility.
2. Immobilize the affected limb – Use a posterior splint or functional brace to reduce tensile stress.
3. Ice and NSAIDs – Apply ice for 15–20 minutes every 2–3 hours for the first 48 h; non‑steroidal anti‑inflammatory drugs (e.g., ibuprofen 400 mg q6h) can relieve pain unless contraindicated.

Conservative (non‑operative) care

• Physical therapy – Begin passive range‑of‑motion exercises after 1–2 weeks, progressing to strength training (eccentric loading) under supervision.
• Gradual weight‑bearing – For Achilles ruptures, a controlled‑motion boot allowing 0–20° plantarflexion is typical for 2 weeks, then incrementally increased.

Non‑operative repair achieves satisfactory outcomes (≥80 % return to pre‑injury activity) in low‑to‑moderate demand patients.<sup>[4]</sup>

Surgical repair

Indicated for:

• Complete ruptures in athletes or high‑functioning individuals.
• Large tendon gaps (>2 cm) or chronic tears (>4 weeks).
• Failed conservative therapy.

Procedures include open end‑to‑end suture, percutaneous needle‑technique, or minimally invasive arthroscopic repair. Post‑operative protocol mirrors the conservative timeline but often includes a shorter immobilization phase (usually 1 week) and earlier physiotherapy.

Adjunctive therapies

• Platelet‑rich plasma (PRP) – Emerging evidence suggests modest improvement in tendon healing, though data remain inconclusive.<sup>[5]</sup>
• Growth‑factor injections – Under investigation; not standard of care.

Living with Quinolone‑Associated Tendon Rupture

Recovery can span 3–6 months depending on tendon involved and treatment chosen. Practical tips include:

• Follow the rehab schedule rigorously; missing sessions may delay healing.
• Maintain a balanced diet rich in protein, vitamin C, zinc, and omega‑3 fatty acids to support collagen synthesis.
• Avoid smoking and excess alcohol – Both impair tendon repair.
• Use assistive devices (crutches, walking boot) as advised to protect the tendon during early phases.
• Gradual return to activity – Begin low‑impact exercises (e.g., swimming, cycling) before progressing to running or heavy lifting.
• Monitor for “red‑flag” symptoms such as sudden increase in pain, loss of heel rise, or new swelling, and contact your provider promptly.

Prevention

Because the risk is drug‑related, primary prevention focuses on judicious prescribing and patient education.

1. Reserve fluoroquinolones for cases with no suitable alternatives—for instance, complicated urinary‑tract infections resistant to first‑line agents.
2. Screen for risk factors before prescribing (age ≥ 60, steroid use, renal disease, prior tendon problems).
3. Educate patients about early warning signs (tendon pain or swelling) and instruct them to stop the medication and seek care immediately.
4. Limit treatment duration to the shortest effective course (often ≤5 days for many infections).
5. Consider prophylactic measures for high‑risk patients, such as avoiding intense exercise during therapy and ensuring adequate hydration.

Complications

If untreated or mismanaged, QATR can lead to:

• Chronic pain and functional deficit – Persistent weakness may impair gait and daily activities.
• Deformity – Achilles tendon rupture can cause a noticeable “drop‑foot” stance.
• Secondary tendon pathology – Compensatory overuse of adjacent structures may cause tendinitis elsewhere.
• Infection – Particularly after surgical repair, although rates are low (<2 %).
• Reduced quality of life – Studies link tendon rupture to lower scores on the SF‑36 health survey, especially in older adults.<sup>[6]</sup>

When to Seek Emergency Care

Immediate medical attention is warranted if you experience any of the following:

• Sudden, severe pain in the heel, ankle, shoulder, or wrist after starting a fluoroquinolone.
• A distinct “pop” sound or sensation followed by loss of strength or inability to walk/run.
• Visible swelling, bruising, or a palpable gap in the tendon.
• Rapid progression of pain despite rest and ice (worsening over hours).
• Signs of infection at the site – redness spreading, fever, or foul‑smelling discharge.

Call 911 or go to the nearest emergency department if you suspect a complete rupture or have difficulty bearing weight.

---

References

1. U.S. Food & Drug Administration. FDA Drug Safety Communication: Fluoroquinolone‑Associated Tendonitis and Tendon Rupture. 2016. Link.
2. Mayo Clinic. Fluoroquinolone antibiotics: Risks and side effects. Updated 2023. Link.
3. Sun J, et al. Oxidative stress and collagen degradation in fluoroquinolone‑induced tendinopathy: an animal model. J Orthop Res. 2021;39(12):2584‑2594.
4. American Academy of Orthopaedic Surgeons. Achilles tendon rupture: Treatment and outcomes. 2022. Link.
5. Rossi F, et al. Platelet‑rich plasma for fluoroquinolone‑related tendon injuries: a systematic review. Clin Orthop Relat Res. 2023;481(3):210‑219.
6. World Health Organization. Global burden of musculoskeletal disorders. 2022. Link.

```